PB
Pioneera Biosciences develops next-generation immunotherapies, including CAR-X "living drugs," using an AI-driven design platform called Discovery 4.0™. This technology engineers superior Chimeric Antigen Receptors (CARs) and other constructs to prevent antigen escape in cell and gene therapies. The company focuses on creating safer, more effective treatments for oncology and autoimmune diseases through intelligent construct discovery.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Pioneera Biosciences develops next-generation immunotherapies, including CAR-X "living drugs," using an AI-driven design platform called Discovery 4.0™. This technology engineers superior Chimeric Antigen Receptors (CARs) and other constructs to prevent antigen escape in cell and gene therapies. The company focuses on creating safer, more effective treatments for oncology and autoimmune diseases through intelligent construct discovery.